Development of medical countermeasures to mitigate or treat the gastrointestinal acute radiation syndrome after a nuclear or radiation incident

Ended Indefinite Delivery Contract Awarded Last action

Contract number
HHSN272201300021C
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$7,420,555.69
Award type
Multiple award
Who can order
Only the awarding agency
NAICS code
541711 Research and Development in Biotechnology
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 10 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 14 $396,356
Funding Only Action 13 $447,030
Funding Only Action 12 $98,247
Other Administrative Action 11 $0
Other Administrative Action 10 $0
Supplemental Agreement for work within scope 9 $107,281
Funding Only Action 8 $375,157
Other Administrative Action 7 $0
Other Administrative Action 6 $0
Other Administrative Action 5 $0
Other Administrative Action 4 $0
Exercise an Option 3 $1,998,223
Other Administrative Action 2 $0
Exercise an Option 1 $1,998,947
Original award $1,999,315
Show all 15

Quick answers

Who was awarded contract HHSN272201300021C?

HHSN272201300021C was awarded to Rxbio, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 24, 2013.

How much is contract HHSN272201300021C worth?

HHSN272201300021C's own ceiling is $7,420,556.

Who can order from contract HHSN272201300021C?

HHSN272201300021C is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSN272201300021C competed?

The extent of competition for HHSN272201300021C was full and open competition. The government received 10 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login